Premium
P2‐392: Predictive factors of discontinuation and switch of cholinesterase inhibitors in Alzheimer's disease
Author(s) -
Gardette Virginie,
Andrieu Sandrine,
Gillette-Guyonnet Sophie,
Nourhashémi Fati,
Ousset Pierre Jean,
Cantet Christelle,
Lapeyre-Mestre Maryse,
Montastruc Jean-Louis,
Vellas Bruno
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.1470
Subject(s) - galantamine , discontinuation , rivastigmine , medicine , hazard ratio , donepezil , context (archaeology) , cohort , proportional hazards model , cholinesterase , dementia , disease , confidence interval , paleontology , biology
Virginie Gardette, Sandrine Andrieu, Sophie Gillette-Guyonnet, Fati Nourhashémi, Pierre Jean Ousset, Christelle Cantet, Maryse Lapeyre-Mestre, Jean-Louis Montastruc, Bruno Vellas, Department of Epidemiology and Public Health, Univ Toulouse III, INSERM U558, Toulouse, France; Gerontopole, Toulouse, France; Gerontopole, CHU Toulouse, Department of Geriatric Medicine, Toulouse, France; Inserm, U558, Toulouse, France; Gerontopole, CHU Toulouse, Department of Geriatric Medicine, INSERM U558, Toulouse, France; Service de Pharmacologie Clinique, EA 3696 , Faculté de Médecine, Gérontopôle, CHU de Toulouse, Université de Toulouse, Toulouse, France. Contact e-mail: gardette@cict.fr